@article{hbkup:/content/journals/10.5339/avi.2014.4, author = "Cartwright, Andrea Lynn and Wilby, Kyle John", title = "A critical evidence-based summary of the use of beta-blockers in stable coronary artery disease", journal= "Avicenna", year = "2014", volume = "2014", number = "1", pages = "", doi = "https://doi.org/10.5339/avi.2014.4", url = "https://www.qscience.com/content/journals/10.5339/avi.2014.4", publisher = "Hamad bin Khalifa University Press (HBKU Press)", issn = "2220-2749", type = "Journal Article", keywords = "beta-blocker", keywords = "evidence based medicine", keywords = "coronary artery disease", eid = "4", abstract = "Current clinical recommendations for patients with stable coronary artery disease (CAD) and those post-acute coronary syndromes (ACS) suggest initiation of patients on dual antiplatelet therapy, an angiotensin-converting enzyme (ACE) inhibitor, a beta-blocker and an HMG-CoA reductase inhibitor prior to hospital discharge. Commonly, this drug regimen is continued indefinitely. More recently, however, emerging evidence suggests that long-term therapy with beta-blockers may in fact be of no benefit to patients with stable CAD. This evidence-based review will summarize the current practice recommendations, as well as provide a critical analysis of available literature regarding beta-blockers in stable CAD. Both efficacy and safety will be considered and implications for current clinical practice will be discussed.", }